Industry Research Reports
Home > Reports > Service & Software > Global Real World Data Solution in Medical Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Real World Data Solution in Medical Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 160 Pages
Report ld: 4906573
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Real World Data Solution in Medical market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Real world data (RWD) in medicine is data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings, including but not limited to electronic health records, health insurance claims and patient surveys.
From a downstream perspective, Oncology accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Real World Data Solution in Medical leading manufacturers including LexisNexis Risk Solutions, Oracle, Citeline, TransCelerate BioPharma, Evidera, Evaluate, Certara, Clinerion, Optum, Inc, Clarivate, etc., dominate supply; the top five capture approximately % of global revenue, with LexisNexis Risk Solutions leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Real World Data Solution in Medical market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- LexisNexis Risk Solutions
- Oracle
- Citeline
- TransCelerate BioPharma
- Evidera
- Evaluate
- Certara
- Clinerion
- Optum, Inc
- Clarivate
- IQVIA
- PerkinElmer
- SAS Institute
- Flatiron Health
- Inovalon
- ICON
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Receipt Data
- DPC (Diagnosis Procedure Combination)
- Electronic Medical Record Data
- Medical Checkup Data
- Patient Registry Data
- Others
Segment by Application
- Oncology
- Neurology
- Immunology
- Cardiovascular Diseases
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Real World Data Solution in Medical study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Real World Data Solution in Medical: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Real World Data Solution in Medical Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Receipt Data
1.2.3 DPC (Diagnosis Procedure Combination)
1.2.4 Electronic Medical Record Data
1.2.5 Medical Checkup Data
1.2.6 Patient Registry Data
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Real World Data Solution in Medical Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Immunology
1.3.5 Cardiovascular Diseases
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Real World Data Solution in Medical Revenue Estimates and Forecasts 2020-2031
2.2 Global Real World Data Solution in Medical Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Real World Data Solution in Medical Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Real World Data Solution in Medical Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Receipt Data Market Size by Players
3.3.2 DPC (Diagnosis Procedure Combination) Market Size by Players
3.3.3 Electronic Medical Record Data Market Size by Players
3.3.4 Medical Checkup Data Market Size by Players
3.3.5 Patient Registry Data Market Size by Players
3.3.6 Others Market Size by Players
3.4 Global Real World Data Solution in Medical Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Real World Data Solution in Medical Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Real World Data Solution in Medical Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Real World Data Solution in Medical Market Size by Type (2020-2031)
6.4 North America Real World Data Solution in Medical Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Real World Data Solution in Medical Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Real World Data Solution in Medical Market Size by Type (2020-2031)
7.4 Europe Real World Data Solution in Medical Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Real World Data Solution in Medical Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Real World Data Solution in Medical Market Size by Type (2020-2031)
8.4 Asia-Pacific Real World Data Solution in Medical Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Real World Data Solution in Medical Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Real World Data Solution in Medical Market Size by Type (2020-2031)
9.4 Central and South America Real World Data Solution in Medical Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Real World Data Solution in Medical Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Real World Data Solution in Medical Market Size by Type (2020-2031)
10.4 Middle East and Africa Real World Data Solution in Medical Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Real World Data Solution in Medical Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 LexisNexis Risk Solutions
11.1.1 LexisNexis Risk Solutions Corporation Information
11.1.2 LexisNexis Risk Solutions Business Overview
11.1.3 LexisNexis Risk Solutions Real World Data Solution in Medical Product Features and Attributes
11.1.4 LexisNexis Risk Solutions Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.1.5 LexisNexis Risk Solutions Real World Data Solution in Medical Revenue by Product in 2024
11.1.6 LexisNexis Risk Solutions Real World Data Solution in Medical Revenue by Application in 2024
11.1.7 LexisNexis Risk Solutions Real World Data Solution in Medical Revenue by Geographic Area in 2024
11.1.8 LexisNexis Risk Solutions Real World Data Solution in Medical SWOT Analysis
11.1.9 LexisNexis Risk Solutions Recent Developments
11.2 Oracle
11.2.1 Oracle Corporation Information
11.2.2 Oracle Business Overview
11.2.3 Oracle Real World Data Solution in Medical Product Features and Attributes
11.2.4 Oracle Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.2.5 Oracle Real World Data Solution in Medical Revenue by Product in 2024
11.2.6 Oracle Real World Data Solution in Medical Revenue by Application in 2024
11.2.7 Oracle Real World Data Solution in Medical Revenue by Geographic Area in 2024
11.2.8 Oracle Real World Data Solution in Medical SWOT Analysis
11.2.9 Oracle Recent Developments
11.3 Citeline
11.3.1 Citeline Corporation Information
11.3.2 Citeline Business Overview
11.3.3 Citeline Real World Data Solution in Medical Product Features and Attributes
11.3.4 Citeline Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.3.5 Citeline Real World Data Solution in Medical Revenue by Product in 2024
11.3.6 Citeline Real World Data Solution in Medical Revenue by Application in 2024
11.3.7 Citeline Real World Data Solution in Medical Revenue by Geographic Area in 2024
11.3.8 Citeline Real World Data Solution in Medical SWOT Analysis
11.3.9 Citeline Recent Developments
11.4 TransCelerate BioPharma
11.4.1 TransCelerate BioPharma Corporation Information
11.4.2 TransCelerate BioPharma Business Overview
11.4.3 TransCelerate BioPharma Real World Data Solution in Medical Product Features and Attributes
11.4.4 TransCelerate BioPharma Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.4.5 TransCelerate BioPharma Real World Data Solution in Medical Revenue by Product in 2024
11.4.6 TransCelerate BioPharma Real World Data Solution in Medical Revenue by Application in 2024
11.4.7 TransCelerate BioPharma Real World Data Solution in Medical Revenue by Geographic Area in 2024
11.4.8 TransCelerate BioPharma Real World Data Solution in Medical SWOT Analysis
11.4.9 TransCelerate BioPharma Recent Developments
11.5 Evidera
11.5.1 Evidera Corporation Information
11.5.2 Evidera Business Overview
11.5.3 Evidera Real World Data Solution in Medical Product Features and Attributes
11.5.4 Evidera Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.5.5 Evidera Real World Data Solution in Medical Revenue by Product in 2024
11.5.6 Evidera Real World Data Solution in Medical Revenue by Application in 2024
11.5.7 Evidera Real World Data Solution in Medical Revenue by Geographic Area in 2024
11.5.8 Evidera Real World Data Solution in Medical SWOT Analysis
11.5.9 Evidera Recent Developments
11.6 Evaluate
11.6.1 Evaluate Corporation Information
11.6.2 Evaluate Business Overview
11.6.3 Evaluate Real World Data Solution in Medical Product Features and Attributes
11.6.4 Evaluate Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.6.5 Evaluate Recent Developments
11.7 Certara
11.7.1 Certara Corporation Information
11.7.2 Certara Business Overview
11.7.3 Certara Real World Data Solution in Medical Product Features and Attributes
11.7.4 Certara Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.7.5 Certara Recent Developments
11.8 Clinerion
11.8.1 Clinerion Corporation Information
11.8.2 Clinerion Business Overview
11.8.3 Clinerion Real World Data Solution in Medical Product Features and Attributes
11.8.4 Clinerion Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.8.5 Clinerion Recent Developments
11.9 Optum, Inc
11.9.1 Optum, Inc Corporation Information
11.9.2 Optum, Inc Business Overview
11.9.3 Optum, Inc Real World Data Solution in Medical Product Features and Attributes
11.9.4 Optum, Inc Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.9.5 Optum, Inc Recent Developments
11.10 Clarivate
11.10.1 Clarivate Corporation Information
11.10.2 Clarivate Business Overview
11.10.3 Clarivate Real World Data Solution in Medical Product Features and Attributes
11.10.4 Clarivate Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 IQVIA
11.11.1 IQVIA Corporation Information
11.11.2 IQVIA Business Overview
11.11.3 IQVIA Real World Data Solution in Medical Product Features and Attributes
11.11.4 IQVIA Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.11.5 IQVIA Recent Developments
11.12 PerkinElmer
11.12.1 PerkinElmer Corporation Information
11.12.2 PerkinElmer Business Overview
11.12.3 PerkinElmer Real World Data Solution in Medical Product Features and Attributes
11.12.4 PerkinElmer Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.12.5 PerkinElmer Recent Developments
11.13 SAS Institute
11.13.1 SAS Institute Corporation Information
11.13.2 SAS Institute Business Overview
11.13.3 SAS Institute Real World Data Solution in Medical Product Features and Attributes
11.13.4 SAS Institute Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.13.5 SAS Institute Recent Developments
11.14 Flatiron Health
11.14.1 Flatiron Health Corporation Information
11.14.2 Flatiron Health Business Overview
11.14.3 Flatiron Health Real World Data Solution in Medical Product Features and Attributes
11.14.4 Flatiron Health Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.14.5 Flatiron Health Recent Developments
11.15 Inovalon
11.15.1 Inovalon Corporation Information
11.15.2 Inovalon Business Overview
11.15.3 Inovalon Real World Data Solution in Medical Product Features and Attributes
11.15.4 Inovalon Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.15.5 Inovalon Recent Developments
11.16 ICON
11.16.1 ICON Corporation Information
11.16.2 ICON Business Overview
11.16.3 ICON Real World Data Solution in Medical Product Features and Attributes
11.16.4 ICON Real World Data Solution in Medical Revenue and Gross Margin (2020-2025)
11.16.5 ICON Recent Developments
12 Real World Data Solution in MedicalIndustry Chain Analysis
12.1 Real World Data Solution in Medical Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Real World Data Solution in Medical Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Real World Data Solution in Medical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Real World Data Solution in Medical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Real World Data Solution in Medical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Real World Data Solution in Medical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Real World Data Solution in Medical Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Real World Data Solution in Medical Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Real World Data Solution in Medical Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Real World Data Solution in Medical Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Real World Data Solution in Medical by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real World Data Solution in Medical as of 2024)
Table 11. Global Real World Data Solution in Medical Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Real World Data Solution in Medical Companies Headquarters
Table 13. Global Real World Data Solution in Medical Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Real World Data Solution in Medical Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Real World Data Solution in Medical Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Real World Data Solution in Medical Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Real World Data Solution in Medical Revenue by Application (2026-2031) & (US$ Million)
Table 21. Real World Data Solution in Medical High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Real World Data Solution in Medical Growth Accelerators and Market Barriers
Table 25. North America Real World Data Solution in Medical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Real World Data Solution in Medical Growth Accelerators and Market Barriers
Table 27. Europe Real World Data Solution in Medical Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Real World Data Solution in Medical Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Real World Data Solution in Medical Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Real World Data Solution in Medical Investment Opportunities and Key Challenges
Table 31. Central and South America Real World Data Solution in Medical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Real World Data Solution in Medical Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Real World Data Solution in Medical Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. LexisNexis Risk Solutions Corporation Information
Table 35. LexisNexis Risk Solutions Description and Major Businesses
Table 36. LexisNexis Risk Solutions Product Features and Attributes
Table 37. LexisNexis Risk Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. LexisNexis Risk Solutions Revenue Proportion by Product in 2024
Table 39. LexisNexis Risk Solutions Revenue Proportion by Application in 2024
Table 40. LexisNexis Risk Solutions Revenue Proportion by Geographic Area in 2024
Table 41. LexisNexis Risk Solutions Real World Data Solution in Medical SWOT Analysis
Table 42. LexisNexis Risk Solutions Recent Developments
Table 43. Oracle Corporation Information
Table 44. Oracle Description and Major Businesses
Table 45. Oracle Product Features and Attributes
Table 46. Oracle Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Oracle Revenue Proportion by Product in 2024
Table 48. Oracle Revenue Proportion by Application in 2024
Table 49. Oracle Revenue Proportion by Geographic Area in 2024
Table 50. Oracle Real World Data Solution in Medical SWOT Analysis
Table 51. Oracle Recent Developments
Table 52. Citeline Corporation Information
Table 53. Citeline Description and Major Businesses
Table 54. Citeline Product Features and Attributes
Table 55. Citeline Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Citeline Revenue Proportion by Product in 2024
Table 57. Citeline Revenue Proportion by Application in 2024
Table 58. Citeline Revenue Proportion by Geographic Area in 2024
Table 59. Citeline Real World Data Solution in Medical SWOT Analysis
Table 60. Citeline Recent Developments
Table 61. TransCelerate BioPharma Corporation Information
Table 62. TransCelerate BioPharma Description and Major Businesses
Table 63. TransCelerate BioPharma Product Features and Attributes
Table 64. TransCelerate BioPharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. TransCelerate BioPharma Revenue Proportion by Product in 2024
Table 66. TransCelerate BioPharma Revenue Proportion by Application in 2024
Table 67. TransCelerate BioPharma Revenue Proportion by Geographic Area in 2024
Table 68. TransCelerate BioPharma Real World Data Solution in Medical SWOT Analysis
Table 69. TransCelerate BioPharma Recent Developments
Table 70. Evidera Corporation Information
Table 71. Evidera Description and Major Businesses
Table 72. Evidera Product Features and Attributes
Table 73. Evidera Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Evidera Revenue Proportion by Product in 2024
Table 75. Evidera Revenue Proportion by Application in 2024
Table 76. Evidera Revenue Proportion by Geographic Area in 2024
Table 77. Evidera Real World Data Solution in Medical SWOT Analysis
Table 78. Evidera Recent Developments
Table 79. Evaluate Corporation Information
Table 80. Evaluate Description and Major Businesses
Table 81. Evaluate Product Features and Attributes
Table 82. Evaluate Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Evaluate Recent Developments
Table 84. Certara Corporation Information
Table 85. Certara Description and Major Businesses
Table 86. Certara Product Features and Attributes
Table 87. Certara Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Certara Recent Developments
Table 89. Clinerion Corporation Information
Table 90. Clinerion Description and Major Businesses
Table 91. Clinerion Product Features and Attributes
Table 92. Clinerion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Clinerion Recent Developments
Table 94. Optum, Inc Corporation Information
Table 95. Optum, Inc Description and Major Businesses
Table 96. Optum, Inc Product Features and Attributes
Table 97. Optum, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Optum, Inc Recent Developments
Table 99. Clarivate Corporation Information
Table 100. Clarivate Description and Major Businesses
Table 101. Clarivate Product Features and Attributes
Table 102. Clarivate Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Clarivate Recent Developments
Table 104. IQVIA Corporation Information
Table 105. IQVIA Description and Major Businesses
Table 106. IQVIA Product Features and Attributes
Table 107. IQVIA Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. IQVIA Recent Developments
Table 109. PerkinElmer Corporation Information
Table 110. PerkinElmer Description and Major Businesses
Table 111. PerkinElmer Product Features and Attributes
Table 112. PerkinElmer Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. PerkinElmer Recent Developments
Table 114. SAS Institute Corporation Information
Table 115. SAS Institute Description and Major Businesses
Table 116. SAS Institute Product Features and Attributes
Table 117. SAS Institute Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. SAS Institute Recent Developments
Table 119. Flatiron Health Corporation Information
Table 120. Flatiron Health Description and Major Businesses
Table 121. Flatiron Health Product Features and Attributes
Table 122. Flatiron Health Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Flatiron Health Recent Developments
Table 124. Inovalon Corporation Information
Table 125. Inovalon Description and Major Businesses
Table 126. Inovalon Product Features and Attributes
Table 127. Inovalon Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Inovalon Recent Developments
Table 129. ICON Corporation Information
Table 130. ICON Description and Major Businesses
Table 131. ICON Product Features and Attributes
Table 132. ICON Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. ICON Recent Developments
Table 134. Raw Materials Key Suppliers
Table 135. Distributors List
Table 136. Market Trends and Market Evolution
Table 137. Market Drivers and Opportunities
Table 138. Market Challenges, Risks, and Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Real World Data Solution in Medical Product Picture
Figure 2. Global Real World Data Solution in Medical Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Receipt Data Product Picture
Figure 4. DPC (Diagnosis Procedure Combination) Product Picture
Figure 5. Electronic Medical Record Data Product Picture
Figure 6. Medical Checkup Data Product Picture
Figure 7. Patient Registry Data Product Picture
Figure 8. Others Product Picture
Figure 9. Global Real World Data Solution in Medical Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 10. Oncology
Figure 11. Neurology
Figure 12. Immunology
Figure 13. Cardiovascular Diseases
Figure 14. Other
Figure 15. Real World Data Solution in Medical Report Years Considered
Figure 16. Global Real World Data Solution in Medical Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 18. Global Real World Data Solution in Medical Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 19. Global Real World Data Solution in Medical Revenue Market Share by Region (2020-2031)
Figure 20. Global Real World Data Solution in Medical Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Receipt Data Revenue Market Share by Player in 2024
Figure 23. DPC (Diagnosis Procedure Combination) Revenue Market Share by Player in 2024
Figure 24. Electronic Medical Record Data Revenue Market Share by Player in 2024
Figure 25. Medical Checkup Data Revenue Market Share by Player in 2024
Figure 26. Patient Registry Data Revenue Market Share by Player in 2024
Figure 27. Others Revenue Market Share by Player in 2024
Figure 28. Global Real World Data Solution in Medical Revenue Market Share by Type (2020-2031)
Figure 29. Global Real World Data Solution in Medical Revenue Market Share by Application (2020-2031)
Figure 30. North America Real World Data Solution in Medical Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Players Real World Data Solution in Medical Revenue (US$ Million) in 2024
Figure 32. North America Real World Data Solution in Medical Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Real World Data Solution in Medical Revenue (US$ Million) by Application (2020-2031)
Figure 34. US Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 35. Canada Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 36. Mexico Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 37. Europe Real World Data Solution in Medical Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Players Real World Data Solution in Medical Revenue (US$ Million) in 2024
Figure 39. Europe Real World Data Solution in Medical Revenue (US$ Million) by Type (2020-2031)
Figure 40. Europe Real World Data Solution in Medical Revenue (US$ Million) by Application (2020-2031)
Figure 41. Germany Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 42. France Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 43. U.K. Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 44. Italy Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 45. Russia Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 46. Asia-Pacific Real World Data Solution in Medical Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Asia-Pacific Top 8 Players Real World Data Solution in Medical Revenue (US$ Million) in 2024
Figure 48. Asia-Pacific Real World Data Solution in Medical Revenue (US$ Million) by Type (2020-2031)
Figure 49. Asia-Pacific Real World Data Solution in Medical Revenue (US$ Million) by Application (2020-2031)
Figure 50. Indonesia Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 51. Japan Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 52. South Korea Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 53. Australia Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 54. India Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 55. Indonesia Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 56. Vietnam Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 57. Malaysia Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 58. Philippines Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 59. Singapore Real World Data Solution in Medical Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Real World Data Solution in Medical Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Central and South America Top 5 Players Real World Data Solution in Medical Revenue (US$ Million) in 2024
Figure 62. Central and South America Real World Data Solution in Medical Revenue (US$ Million) by Type (2020-2031)
Figure 63. Central and South America Real World Data Solution in Medical Revenue (US$ Million) by Application (2020-2031)
Figure 64. Brazil Real World Data Solution in Medical Revenue (2020-2025) & (US$ Million)
Figure 65. Argentina Real World Data Solution in Medical Revenue (2020-2025) & (US$ Million)
Figure 66. Middle East and Africa Real World Data Solution in Medical Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Middle East and Africa Top 5 Players Real World Data Solution in Medical Revenue (US$ Million) in 2024
Figure 68. South America Real World Data Solution in Medical Revenue (US$ Million) by Type (2020-2031)
Figure 69. Middle East and Africa Real World Data Solution in Medical Revenue (US$ Million) by Application (2020-2031)
Figure 70. GCC Countries Real World Data Solution in Medical Revenue (2020-2025) & (US$ Million)
Figure 71. Israel Real World Data Solution in Medical Revenue (2020-2025) & (US$ Million)
Figure 72. Egypt Real World Data Solution in Medical Revenue (2020-2025) & (US$ Million)
Figure 73. South Africa Real World Data Solution in Medical Revenue (2020-2025) & (US$ Million)
Figure 74. Real World Data Solution in Medical Industry Chain Mapping
Figure 75. Channels of Distribution (Direct Vs Distribution)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Real World Data Solution in Medical market?
The top companies in the global Real World Data Solution in Medical market are LexisNexis Risk Solutions、Oracle、Citeline.
Related Reports
Global Real World Data Solution in Medical Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Real World Data Solution in Medical market is projected to grow from US$ 1185 million in 2025 to US$ 1959 million by 2032, at a CAGR of 7.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-28
Pages: 131
USD 4900.00
(Single User License)
Global Real World Data Solution in Medical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Real World Data Solution in Medical market size was US$ 1185 million in 2025 and is forecast to reach a readjusted size of US$ 1959 million by 2032 with a CAGR of 7.4% during the forecast period 2026-2032.
Published Date: 2026-08-28
Pages: 116
USD 4250.00
(Single User License)
Real World Data Solution in Medical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Real World Data Solution in Medical was estimated to be worth US$ 1185 million in 2025 and is projected to reach US$ 1959 million, growing at a CAGR of 7.4% from 2026 to 2032.
Published Date: 2026-08-28
Pages: 120
USD 3950.00
(Single User License)
Global Real World Data Solution in Medical Market Research Report 2026
The global Real World Data Solution in Medical market was valued at US$ 1185 million in 2025 and is anticipated to reach US$ 1959 million by 2032, at a CAGR of 7.4% from 2026 to 2032.
Published Date: 2026-08-28
Pages: 118
USD 2900.00
(Single User License)
Global Real World Data Solution in Medical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Real World Data Solution in Medical market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 109
USD 4250.00
(Single User License)
Real World Data Solution in Medical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Real World Data Solution in Medical was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 125
USD 3950.00
(Single User License)
Global Real World Data Solution in Medical Market Research Report 2025
The global market for Real World Data Solution in Medical was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 94
USD 2900.00
(Single User License)
Global Real World Data Solution in Medical Market Insights, Forecast to 2030
Real world data (RWD) in medicine is data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings, including but not limited to electronic health records, health insurance claims and patient surveys.
Published Date: 2024-05-22
Pages: 151
USD 4900.00
(Single User License)
Global and United States Real World Data Solution in Medical Market Report & Forecast 2024-2030
Real world data (RWD) in medicine is data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings, including but not limited to electronic health records, health insurance claims and patient surveys.
Published Date: 2024-05-14
Pages: 130
USD 4350.00
(Single User License)
Global Real World Data Solution in Medical Market Research Report 2024
Real world data (RWD) in medicine is data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings, including but not limited to electronic health records, health insurance claims and patient surveys.
Published Date: 2024-05-14
Pages: 94
USD 2900.00
(Single User License)
Global Real World Data Solution in Medical Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Real World Data Solution in Medical market is projected to grow from US$ 1185 million in 2025 to US$ 1959 million by 2032, at a CAGR of 7.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-28
Pages: 131
USD 4900.00 (Single User License)Global Real World Data Solution in Medical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Real World Data Solution in Medical market size was US$ 1185 million in 2025 and is forecast to reach a readjusted size of US$ 1959 million by 2032 with a CAGR of 7.4% during the forecast period 2026-2032.
Published: 2026-08-28
Pages: 116
USD 4250.00 (Single User License)Real World Data Solution in Medical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Real World Data Solution in Medical was estimated to be worth US$ 1185 million in 2025 and is projected to reach US$ 1959 million, growing at a CAGR of 7.4% from 2026 to 2032.
Published: 2026-08-28
Pages: 120
USD 3950.00 (Single User License)Global Real World Data Solution in Medical Market Research Report 2026
The global Real World Data Solution in Medical market was valued at US$ 1185 million in 2025 and is anticipated to reach US$ 1959 million by 2032, at a CAGR of 7.4% from 2026 to 2032.
Published: 2026-08-28
Pages: 118
USD 2900.00 (Single User License)Global Real World Data Solution in Medical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Real World Data Solution in Medical market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 109
USD 4250.00 (Single User License)Real World Data Solution in Medical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Real World Data Solution in Medical was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 125
USD 3950.00 (Single User License)Global Real World Data Solution in Medical Market Research Report 2025
The global market for Real World Data Solution in Medical was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 94
USD 2900.00 (Single User License)Global Real World Data Solution in Medical Market Insights, Forecast to 2030
Real world data (RWD) in medicine is data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings, including but not limited to electronic health records, health insurance claims and patient surveys.
Published: 2024-05-22
Pages: 151
USD 4900.00 (Single User License)Global and United States Real World Data Solution in Medical Market Report & Forecast 2024-2030
Real world data (RWD) in medicine is data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings, including but not limited to electronic health records, health insurance claims and patient surveys.
Published: 2024-05-14
Pages: 130
USD 4350.00 (Single User License)Global Real World Data Solution in Medical Market Research Report 2024
Real world data (RWD) in medicine is data derived from a number of sources that are associated with outcomes in a heterogeneous patient population in real-world settings, including but not limited to electronic health records, health insurance claims and patient surveys.
Published: 2024-05-14
Pages: 94
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now